GE HealthCare Technologies (FRA:L0T) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L0T GE HealthCare Technologies Inc FRA:L0T
72 GF Score
Price €54.14
GF Value €76.30
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies FFO per Share?

FFO per Share only applies to REITs.

FRA:L0T
72GF Score
GE HealthCare Technologies Inc FRA:L0T
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GE HealthCare Technologies (FRA:L0T) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of €54.14 is trading 29% below its estimated GF Value™ of €76.30. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for FRA:L0T:

  • FFO per Share:
  • GF Value™: €76.30 vs. price of €54.14 (29% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score

Get the complete analysis for FRA:L0T

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€54.14
Price
€76.30
GF Value